By coupling brain-targeted nanocarriers with patient-specific metabolic fingerprints, a gene-matched, pathway-matched strategy is emergingpositioning riboflavin at the center of personalized, systems-level interventions for both rare flavoproteinopathies and common neurodegenerative disorders
Gradual Dose Escalation: The clinical data consistently show that gradual dose escalation is the most effective strategy for minimizing these effects
Its apparent that brands are targeting Gen Z, keenly aware that young people are willing to cut back on other luxuries to have more money to spend on wellness products
Khi tim truyn, cn thc hin vi tc chm
10.1007/s00203-017-1459-x Summary Keywords gut microbiota, gastrointestinal diseases, cancer, therapy, dysbiosis Citation Ullah H, Arbab S, Chang C, Bibi S, Muhammad N, Rehman SU, Suleman, Ullah I, Hassan IU, Tian Y and Li K (2025) Gut microbiota therapy in gastrointestinal diseases